[1] Xu B, et al, FAVOR III China study group. Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial. Lancet. 2021 Nov 3;S0140-6736(21)02248-0. doi: 10.1016/S0140-6736(21)02248-0.
[2] Tu S, et al. Diagnostic accuracy of quantitative flow ratio for assessment of coronary stenosis significance from a single angiographic view: A novel method based on bifurcation fractal law. Catheter Cardiovasc Interv. Catheter Cardiovasc Interv. 2021 May 1;97 Suppl 2:1040-1047
[3] Xu B, et al. Diagnostic Accuracy of Angiography-Based Quantitative Flow Ratio Measurements for Online Assessment of Coronary Stenosis. J Am Coll Cardiol. 2017 Dec 26;70(25):3077-3087
[4] Ding D, et al. Immediate post-procedural functional assessment of percutaneous coronary intervention: current evidence and future directions. European Heart Journal. 2021; 42:2695-2707.
[5] PCR-EAPCI TEXTBOOK: Julien Adjedj, Jelmer Westra, Daixin Ding, Junqing Yang, William Wijns, Shengxian Tu. Computational non-invasive physiological assessment of coronary disease. Computational non-invasive physiological assessment of coronary disease. 2019. VOLUME I, PART II.
Address
Headquarters:A6, Building 1, No.900 Yishan Road, Xuhui District, Shanghai, 200233, China
Contact us
Tel: +86 21 5467 0228
sales@